| J3262 | Injection, tocilizumab, 1 mg | 105,000 | $10 | $525K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 47,040 | $10 | $376.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 26,350 | $10 | $263.5K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,100 | $30 | $207.4K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 40,800 | $1 | $163.2K |
| J0897 | Injection, denosumab, 1 mg | 6,720 | $20 | $121K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 830 | $80 | $69.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 510 | $90 | $45.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 750 | $50 | $38.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 160 | $110 | $17.2K |